APA (7th ed.) Citation

Palsson, O., Love, T. J., Gunnarsdottir, A. I., Gunnarsson, P. S., Runarsdottir, E. E., Krogh, N. S., . . . NordForsk. (2019). Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligible. RMD Open, 5(2), e000984.

Chicago Style (17th ed.) Citation

Palsson, Olafur, et al. "Patients with Psoriatic Arthritis Who Are Not Eligible for Randomised Controlled Trials for TNF Inhibitors Have Treatment Response and Drug Survival Similar to Those Who Are Eligible." RMD Open 5, no. 2 (2019): e000984.

MLA (9th ed.) Citation

Palsson, Olafur, et al. "Patients with Psoriatic Arthritis Who Are Not Eligible for Randomised Controlled Trials for TNF Inhibitors Have Treatment Response and Drug Survival Similar to Those Who Are Eligible." RMD Open, vol. 5, no. 2, 2019, p. e000984.